Block Biosciences is developing first-in-class small molecule therapies combined with a companion diagnostic to prevent brain metastasis-an urgent and underserved cancer complication. Built on novel biology and predictive biomarkers, our proactive approach aims to block metastatic spread before it reaches the brain, extending survival and preserving quality of life for high-risk patients.
Founders
Amie Phinney
Co-Founder
Agata Kieliszek
Co-Founder
Featured Stories
NerView Surgical wins Falcons’ Fortunes 2026 for its precise nerve visualization technology making cancer surgeries safer for patients
The winner of the $100,000 Ernsting Entrepreneurship award at FACIT’s Falcons’ Fortunes pitch competition was awarded to Mann Parikh, Founder...
The Forge Advantage: Mentorship, Momentum and Market-Ready Startups
Parisa Agahi had just earned her masters degree from McMaster’s Biomedical Discovery and Commercialization Program when she was prescribed compression...